日本薬理学会年会要旨集
Online ISSN : 2435-4953
第95回日本薬理学会年会
セッションID: 95_3-P-282
会議情報

一般演題(ポスター)
miR-7-5pの抑制は臨床的放射線抵抗性がん細胞のROSとFe2+量を増加させフェロトーシスを誘導する
*富田 和男桑原 義和五十嵐 健人田中 康一北中 純一北中 順惠栗政 明弘西山 信好佐藤 友昭
著者情報
会議録・要旨集 オープンアクセス

詳細
抄録

We have established and analyzed "clinically relevant radioresistant (CRR) cells" that can survive exposing to 2 Gy/day X-rays for more than 30 days to overcome cancer treatment resistance. CRR cells show resistance against not only radiation but also docetaxel and hydrogen peroxide (H2O2) which is one of the reactive oxygen species (ROS). It has been shown that CRR cells produce less Fe2+, ROS, and lipid peroxidation compared to the parental cells. Furthermore, we have been reported that the expression of miR-7-5p is upregulated in CRR cells and miR7-5p inhibition loses its radioresistance. Therefore, we inhibited miR-7-5p expression in CRR cells by siRNA and investigated the change of Fe2+, ROS, and lipid peroxidation. As a result, miR-7-5p inhibition decreases the amount of Fe2+, ROS, and Liperfluo, which is one of the ferroptosis markers and detects lipid peroxidation. Moreover, miR-7-5p inhibition decreases the gene expression of Ferritin, the iron-binding protein, and arachidonate 12-lipoxygenase (ALOX12), the lipid oxidation enzyme. It has been reported that the overexpression of ALOX12 enhances the ROS amount and lipid peroxidation by H2O2 treatment. Taken together, our results suggest the possibility to overcome the treatment resistance by inhibiting miR-7-5p.

著者関連情報
© 2022 本論文著者
前の記事 次の記事
feedback
Top